Volume 11 - پاییز و زمستان 87-                   mjms 2009, 11 - پاییز و زمستان 87-: 19-30 | Back to browse issues page

XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Jorjani O N, Ghaffarifar F, Sharifi Z, Dalimi A, Hassan Z. Cloning and sequencing of L. major leishmania homologue of receptors for activated C kinase (LACK) gene. mjms. 2009; 11 :19-30
URL: http://mjms.modares.ac.ir/article-30-8296-en.html
1- of Parasitology, School of Medical Sciences, Tarbiat Modares University, Tehran, Iran
2- Associated Professor, Department of Parasitilogy, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran
3- Iranian Blood Transfusion Organization, Tehran, Iran
4- Department of Parasitology, School of Medical Sciences, Tarbiat Modares University, Tehran, Iran
5- Department of Immunology, School of Medical Sciences, Tarbiat Modares University, Tehran, Iran
Abstract:   (9185 Views)
Objective: Leishmaniasis is caused by parasitic protozoa of the genus Leishmania which in the infected host is obligate intracellular parasite. LACK gene is conserved among related Leishmania species. LACK is the immuno-dominant antigen of L.major which is considered as the most promising molecule for a recombinant or DNA vaccine against leishmaniasis. Materials and Methods: In this study the genomic DNA of an Iranian standard strain of Leishmania major (MRHO/IR/75/ER) was ertracted and the LACK gene was amplilified by PCR. Then the PCR product was cloned into pTZ57R/T cloning vector, The PT-LACK recombinant plasmid was extracted from transformed E.coli bacteria (TG1 strain) and sequenced. Results: The LACK gene (Accession no LmjF28.2740) of MRHO/IR/75/ER & L. major was amplified using PCR method. LACK gene was cloned into pTZ57R/T coloning vector. Sequence analysis of the cloned LACK gene showed high homology 89% with LmjF28.2740 (LACK gene). Conclusion: The LACK gene of L.major was cloned in pTZ57R/T vector successfully. Recombinant plasmid was confirmed and could be used for the production of recomiomort antigens is DNA vaccines, for further studies.
Full-Text [PDF 273 kb]   (3259 Downloads)    

Received: 2009/01/3 | Accepted: 2009/01/3

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.